New publication in the Journal of Medicinal Chemistry

C-terminal Modifications of apelin-13 significantly change ligand binding, receptor signaling and hypotensive action.
Murza A, Besserer-Offroy É, Côté J, Bérubé P, Longpré JM, Dumaine R, Lesur O, Auger-Messier M, Leduc R, Sarret P, Marsault E.
J Med Chem. 2015 Mar 12;58(5):2431-40. doi: 10.1021/jm501916k. Epub 2015 Feb 24.
PMID: 25668242